Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Drug resistance mutations among HIV-1 strains from antiretroviral-naive patients in Martinique, French West Indies.

Journal of acquired immune deficiency syndromes (1999) - 1 Dec 1999

Césaire R, Dos Santos G, Abel S, Bera O, Sobesky G, Cabié A

Abstract excerpt

We report on the frequency of genetic mutations associated with drug resistance in antiretroviral treatment-naive patients from Martinique (French West Indies), where zidovudine (ZDV) has been available since 1987 and where combination therapy developed simultaneously with its use in continental France. Genotypic resistance was studied in plasma HIV RNA from samples collected between 1988 and 1998 from 70...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance, Microbial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to HIV Infections

Share to HIV Reverse Transcriptase

Share to Reverse Transcriptase Inhibitors

Share to Zidovudine

Source

Identifiers

PMID: 10634203
DOI: 10.1097/00126334-199912010-00012

Genes

LIPA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Drug resistance mutations among HIV-1 strains from antiretroviral-naive patients in Martinique, French West Indies.PMID 10634203Read ↗

Prevalence of genotypic resistance among antiretroviral drug-naive HIV-1-infected patients in Belgium.Semantic proximity Read ↗

Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in SpainSemantic proximity Read ↗

Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain.Semantic proximity Read ↗

Primary HIV-1 resistance in recently and chronically infected individuals of the Italian Cohort Naive for Antiretrovirals.Semantic proximity Read ↗

Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid.Semantic proximity Read ↗

Profile of drug resistance mutations among HIV-1-infected Tunisian subjects failing antiretroviral therapy.Semantic proximity Read ↗

Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain. The ERASE-2 Study Group.Semantic proximity Read ↗

Resistance to antiretroviral drugs in patients with primary HIV-1 infection. Investigators of the Quebec Primary Infection Study.Semantic proximity Read ↗

Human immunodeficiency virus 1 strains resistant to nucleoside inhibitors of reverse transcriptase in isolates from the Czech Republic as monitored by line probe assay and nucleotide sequencing.Semantic proximity Read ↗

Low prevalence of primary mutations associated with drug resistance in antiviral-naive patients at therapy initiation.Semantic proximity Read ↗

Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. Investigators of the Quebec Primary Infection Study.Semantic proximity Read ↗

High level of primary drug resistance in Mali.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.